TY - JOUR
T1 - Guía de práctica clínica para diagnóstico y tratamiento de Hemofilia en el Seguro Social del Perú (EsSalud)
AU - Herrera-Cunti, Celina
AU - Delgado-Flores, Carolina J.
AU - García-Gomero, David
AU - Taype-Rondan, Alvaro
AU - Chumpitaz-Anchiraico, Gloria
AU - Yanac-Ávila, Rommel
AU - Villar-Alarcón, Carmen Del
AU - Salvador-Salvador, Stefany
AU - Carrera-Acosta, Lourdes
N1 - Publisher Copyright:
© 2022 The Korean Ophthalmological Society.
PY - 2021/10
Y1 - 2021/10
N2 - Background: This article summarizes the clinical practice guide (CPG) for diagnosis and treatment of hemophilia in the Social Security of Peru (EsSalud). Objective: To provide evidence-based clinical recommendations for the diagnosis and treatment of hemophilia in EsSalud. Material and Methods: A guideline development group (GDG) was formed, which included specialist physicians and methodologists, who formulated clinical questions. Systematic searches of systematic reviews were conducted and - when deemed relevant - primary studies in PubMed during 2020 and 2021. Evidence was selected to answer each of the proposed clinical questions. The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. In periodic working meetings, the GEG used the GRADE methodology to review the evidence and formulate recommendations. The CPG was reviewed by external experts before its approval. Results: The CPG addressed 09 clinical questions, divided into 02 topics: diagnosis and treatment. Based on these questions, 05 recommendations were formulated (01 strong and 04 conditional), 51 points of good clinical practice, and 02 flow charts. Conclusion: Evidence-based recommendations were issued for the diagnosis and treatment of persons with hemophilia.
AB - Background: This article summarizes the clinical practice guide (CPG) for diagnosis and treatment of hemophilia in the Social Security of Peru (EsSalud). Objective: To provide evidence-based clinical recommendations for the diagnosis and treatment of hemophilia in EsSalud. Material and Methods: A guideline development group (GDG) was formed, which included specialist physicians and methodologists, who formulated clinical questions. Systematic searches of systematic reviews were conducted and - when deemed relevant - primary studies in PubMed during 2020 and 2021. Evidence was selected to answer each of the proposed clinical questions. The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. In periodic working meetings, the GEG used the GRADE methodology to review the evidence and formulate recommendations. The CPG was reviewed by external experts before its approval. Results: The CPG addressed 09 clinical questions, divided into 02 topics: diagnosis and treatment. Based on these questions, 05 recommendations were formulated (01 strong and 04 conditional), 51 points of good clinical practice, and 02 flow charts. Conclusion: Evidence-based recommendations were issued for the diagnosis and treatment of persons with hemophilia.
KW - Evidence-Based Medicine. (Source: DeCS-BIREME)
KW - GRADE Approach
KW - Hemophilia
KW - Practice Guidelines as Topic
UR - http://www.scopus.com/inward/record.url?scp=85130038084&partnerID=8YFLogxK
U2 - 10.35434/rcmhnaaa.2021.144.1464
DO - 10.35434/rcmhnaaa.2021.144.1464
M3 - Artículo
AN - SCOPUS:85130038084
SN - 2225-5109
VL - 14
SP - 556
EP - 571
JO - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
JF - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
IS - 4
ER -